Topical Rapamycin Reduces Markers of Skin Aging: Pilot Study
GeroScience (2019)
0.1% topical rapamycin applied to hands for 8 months increased collagen VII and reduced p16INK4A (senescence marker) vs placebo.
How it works
Marek's Guided Optimization® Program combines advanced lab testing, a dedicated health coach and medical provider, and a personalized treatment plan, all built around your data.
Resources
The process
Start your assessment
Complete your 45-min intake assessment
Get your labs drawn
4,000 partnered lab locations nationwide
Review with your coach
Screen-by-screen lab review
Receive your protocol
Treatment delivered to your door
Why Marek
The only program pairing you with a dedicated health coach and medical provider, built on precision diagnostics, with no subscription required.
Resources
Meet our co-founder
Derek
Co-Founder · MPMD Podcast
"Over time, I found it incredibly difficult to get medical oversight for myself and my family that reflected the latest research, and that was preventative. That's why I started Marek Health."

What we test
Every client's lab panel is hand-selected from 1,000+ available biomarkers, built around their specific goals.
Panel categories
Resources
Treatments
700+ medical provider-prescribed therapies built from your labs. Browse by category or explore the full formulary.
Rapamycin Cream (Topical Sirolimus)
Topical cream (0.01%)Not available in all statesMarketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
skin
Topical mTORC1 inhibitor for skin anti-aging. Reduces cellular senescence, improves collagen production, and has demonstrated improvement in skin aging markers in pilot studies. Minimal systemic absorption at 0.01% concentration.
Reduces cellular senescence markers in skin
Improves collagen production
Minimal systemic absorption
Novel mechanism distinct from retinoids
No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible
How it works
Topical mTORC1 inhibition in skin fibroblasts and keratinocytes enhances autophagy, reduces cellular senescence (SASP factors), improves collagen synthesis, and may reduce UV-induced photoaging.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Sex hormones
Adrenals & neurosteroids
Growth hormone / IGF-1
Thyroid hormones
Cardiovascular health
Insulin sensitivity
Liver & pancreas
Kidney function
Comprehensive Metabolic Panel (CMP)
Prostate health
Vitamins & minerals
Iron status
Complete Blood Count (CBC)
Clinical evidence
GeroScience (2019)
0.1% topical rapamycin applied to hands for 8 months increased collagen VII and reduced p16INK4A (senescence marker) vs placebo.
Safety profile
FAQ
Topical mTORC1 inhibitor for skin anti-aging. Reduces cellular senescence, improves collagen production, and has demonstrated improvement in skin aging markers in pilot studies. Minimal systemic absorption at 0.01% concentration.
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.